JPX-1188
/ Centessa, Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 07, 2020
Janpix Announces $10 Million Series B Financing to Advance STAT Protein Degrader Pipeline
- "Janpix Inc...announced the closing of a $10 Million Series B financing. This round was led by Medicxi, which initially seeded and funded the series A of the company...'These funds will allow us to advance our first candidate into the clinic while further expanding the pipeline of STAT3 and STAT5 protein degraders and their use.'"
Financing • Hematological Malignancies • Oncology
1 to 1
Of
1
Go to page
1